Advances in the treatment of persistent pulmonary hypertension of the newborn.
Despite an association with meconium and blood aspiration, pneumonia, sepsis, pneumothorax, prematurity, and congenital diaphragmatic hernia, no cause for persistent pulmonary hypertension of the newborn can be found in many cases. This article discusses the advances in current therapies including the promising new therapy of inhaled nitric oxide.
Roberts
J D
JD
Department of Anesthesia, Harvard Medical School, Boston, Massachusetts.
Shaul
P W
PW
D000818:Animals; D015199:Extracorporeal Membrane Oxygenation; D006612:High-Frequency Ventilation; D006801:Humans; D007231:Infant, Newborn; D009569:Nitric Oxide / Q000627:therapeutic use; D010547:Persistent Fetal Circulation Syndrome / Q000628:therapy*; D011652:Pulmonary Circulation / Q000187:drug effects; D012121:Respiration, Artificial; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents; D009569:Nitric Oxide